New therapeutic options for HCV in Central Europe

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61383082%3A_____%2F16%3A00000219" target="_blank" >RIV/61383082:_____/16:00000219 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11110/16:10327740

Result on the web

<a href="https://www.termedia.pl/New-therapeutic-options-for-HCV-in-Central-Europe,80,27219,0,1.html" target="_blank" >https://www.termedia.pl/New-therapeutic-options-for-HCV-in-Central-Europe,80,27219,0,1.html</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.5114/ceh.2016.58850" target="_blank" >10.5114/ceh.2016.58850</a>

Result language

angličtina

Original language name

New therapeutic options for HCV in Central Europe

Original language description

New therapeutic options became available in 2015 in the European Union. We present the availability of interferon-free regimens with direct acting antivirals (DAA) in four Central European countries - the Czech Republic, Hungary, Poland and Slovakia - which despite similar historical, geographical and economic situations demonstrate different systems for access to anti-HCV (hepatitis C virus) medication. Treatment of patients in the Czech Republic was based in 2015 on an exceptional individual reimbursement procedure, but regular reimbursement procedures are expected in 2016. In Hungary the decision for treatment is balanced against budget limitations and the national Priority Index system reflecting stage of liver disease, activity of the disease and predictive factors. A reimbursed interferon (IFN)-free therapeutic program for all genotypes, without restrictions related to hepatic fibrosis and treatment history, is already available in Poland. In Slovakia patients with advanced fibrosis are currently selected for possible IFN-free therapy in 2016.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FE - Other fields of internal medicine

OECD FORD branch

—

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2016

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

CLINICAL AND EXPERIMENTAL HEPATOLOGY

ISSN

2392-1099

e-ISSN

—

Volume of the periodical

2

Issue of the periodical within the volume

1

Country of publishing house

PL - POLAND

Number of pages

5

Pages from-to

7-11

UT code for WoS article

000382013300003

EID of the result in the Scopus database

—